Immunotherapy. Significant overall survival advantage for RCC patients treated with autologous tumor lysate vaccine.
Lisa
L
Hutchinson
D000293:Adolescent; D000328:Adult; D019496:Cancer Vaccines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D055815:Young Adult
D019496:Cancer Vaccines